Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation
- PMID: 12654245
- DOI: 10.1016/s0092-8674(03)00193-4
Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation
Abstract
The p53 tumor suppressor exerts anti-proliferative effects in response to various types of stress including DNA damage and abnormal proliferative signals. Tight regulation of p53 is essential for maintaining normal cell growth and this occurs primarily through posttranslational modifications of p53. Here, we describe Pirh2, a gene regulated by p53 that encodes a RING-H2 domain-containing protein with intrinsic ubiquitin-protein ligase activity. Pirh2 physically interacts with p53 and promotes ubiquitination of p53 independently of Mdm2. Expression of Pirh2 decreases the level of p53 protein and abrogation of endogenous Pirh2 expression increases the level of p53. Furthermore, Pirh2 represses p53 functions including p53-dependent transactivation and growth inhibition. We propose that Pirh2 is involved in the negative regulation of p53 function through physical interaction and ubiquitin-mediated proteolysis. Hence, Pirh2, like Mdm2, participates in an autoregulatory feedback loop that controls p53 function.
Similar articles
-
Differential response between the p53 ubiquitin-protein ligases Pirh2 and MdM2 following DNA damage in human cancer cells.Exp Cell Res. 2006 Oct 15;312(17):3370-8. doi: 10.1016/j.yexcr.2006.07.005. Epub 2006 Jul 21. Exp Cell Res. 2006. PMID: 16934800
-
Identification and characterization of two novel isoforms of Pirh2 ubiquitin ligase that negatively regulate p53 independent of RING finger domains.J Biol Chem. 2009 Aug 14;284(33):21955-21970. doi: 10.1074/jbc.M109.024232. Epub 2009 May 29. J Biol Chem. 2009. PMID: 19483087 Free PMC article.
-
An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo.Oncogene. 2000 May 4;19(19):2312-23. doi: 10.1038/sj.onc.1203593. Oncogene. 2000. PMID: 10822382
-
Pirh2 RING-finger E3 ubiquitin ligase: its role in tumorigenesis and cancer therapy.FEBS Lett. 2012 May 21;586(10):1397-402. doi: 10.1016/j.febslet.2012.03.052. Epub 2012 Apr 3. FEBS Lett. 2012. PMID: 22673504 Free PMC article. Review.
-
The Role of E3 Ligase Pirh2 in Disease.Cells. 2022 Apr 30;11(9):1515. doi: 10.3390/cells11091515. Cells. 2022. PMID: 35563824 Free PMC article. Review.
Cited by
-
Trace elements in pancreatic cancer.Cancer Med. 2024 Jul;13(14):e7454. doi: 10.1002/cam4.7454. Cancer Med. 2024. PMID: 39015024 Free PMC article. Review.
-
Arylamines QSAR-Based Design and Molecular Dynamics of New Phenylthiophene and Benzimidazole Derivatives with Affinity for the C111, Y268, and H73 Sites of SARS-CoV-2 PLpro Enzyme.Pharmaceuticals (Basel). 2024 May 9;17(5):606. doi: 10.3390/ph17050606. Pharmaceuticals (Basel). 2024. PMID: 38794177 Free PMC article.
-
Pirh2 modulates the mitochondrial function and cytochrome c-mediated neuronal death during Alzheimer's disease.Cell Death Dis. 2024 May 13;15(5):331. doi: 10.1038/s41419-024-06662-1. Cell Death Dis. 2024. PMID: 38740775 Free PMC article.
-
RCHY1 and OPTN are required for melanophagy, selective autophagy of melanosomes.Proc Natl Acad Sci U S A. 2024 Apr 2;121(14):e2318039121. doi: 10.1073/pnas.2318039121. Epub 2024 Mar 27. Proc Natl Acad Sci U S A. 2024. PMID: 38536750 Free PMC article.
-
Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy.Cancer Commun (Lond). 2024 Mar;44(3):297-360. doi: 10.1002/cac2.12520. Epub 2024 Feb 4. Cancer Commun (Lond). 2024. PMID: 38311377 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous
